Bicycle Therapeutics announces expansion of management team with appointments of CSO and Business Development Director

Cambridge, UK. Bicycle Therapeutics, a next generation biotherapeutics company developing novel bicyclic peptides, today announced the appointment of Christophe Bonny as Chief Scientific Officer and Jonathan Savidge as Business Development Director. This expansion to the management team reflects the successful development of the company and its technology to the next stage in its evolution. Read More